Bharat Biotech International Limited on Tuesday said its COVID-19 intranasal vaccine iNCOVACC, which is now available on CoWIN portal, is priced at Rs 800 (excluding GST) for private markets and Rs......
The Drugs Controller General of India (DCGI) on Tuesday approved Bharat Biotech's intranasal Covid vaccine for restricted emergency use in those aged above 18 years. "Big Boost to India's Fight......
Union Health Minister Mansukh Mandaviya and Science and Technology Minister Jitendra Singh launched Bharat Biotech's nasal Covid vaccine, iNCOVACC, on the occasion of Republic Day on Thursday.......
In a major boost for Bharat Biotech, the World Health Organisation has accepted its Expression of Interest for COVID-19 vaccine Covaxin and scheduled a pre-submission meeting on June 23, a step......
WHO has urged people at risk to keep up with their vaccinations with boosters. IMAGE: A healthcare worker administers a dose of iNCOVACC, an intranasal vaccine as a booster dose for a senior......
Only five Indian companies would be in a position to choose most available redemption options for their foreign currency convertible bonds (FCCBs), due for redemption this year, according to a......
Those who chatted withmarket expert Pranav Sanghavi on Tuesday expressed concern over the unpredictable state of the stock market and askedfor investment tips. Here isthe transcript: PRANAV......
Speech of P. Chidambaram Minister of Finance PART A Mr. Speaker, Sir, I rise to present the Budget for the year 2005-06. 2. Last year, while presenting the Budget, I had suggested that the vote in......